Changes in insulin like growth factors, myostatin and vascular endothelial growth factor in rat musculus latissimus dorsi by poly-3-hydroxybutyrate implants

Journal of Physiology and Pharmacology

Volumn 60, Issue SUPPL. 3, 2009, Pages 77-81

  Gredes, T ^a   Spassov, A ^a   Mai, R ^a   Mack, H ^b   Loster, Bartlomiej W ^c   Mazurkiewicz Janik, M ^c   Kubein Meesenburg, D ^d   Fanghanel, J ^a   Gedrange, T ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b GRIFFITH UNIVERSITY   (Australia)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^d UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

mRNA; Muscle; Poly(3)hydroxybutyrate; Rat; Real time PCR

Indexed keywords

MESSENGER RNA; MYOSTATIN; POLY(3 HYDROXYBUTYRIC ACID); SOMATOMEDIN B; SOMATOMEDIN C; VASCULOTROPIN;

ANIMAL TISSUE; ARTICLE; BONE PROSTHESIS; CONTROLLED STUDY; GENE EXPRESSION; GENETIC ANALYSIS; LATISSIMUS DORSI MUSCLE; MALE; MOLECULAR INTERACTION; MUSCLE GROWTH; NONHUMAN; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA EXTRACTION; TISSUE HOMOGENATE; TISSUE INTERACTION;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; BONE SUBSTITUTES; HYDROXYBUTYRATES; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MALE; MUSCLE, SKELETAL; MYOSTATIN; OSSIFICATION, HETEROTOPIC; OSTEOGENESIS; POLYESTERS; RANDOM ALLOCATION; RATS; RNA, MESSENGER; TISSUE ENGINEERING; TISSUE SCAFFOLDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 74549189967     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Mai R, Hagedorn MG, Gelinsky M et al. Ectopic bone formation in nude rats using human osteoblasts seeded poly(3)hydroxybutyrate embroidery and hydroxyapatitecollagen tapes constructs. J Craniomaxillofac Surg 2006; 34: 101-109.
2. Mai R, Lux R, Proff P et al. O-phospho-l-serine: a modulator of bone healing in calcium-phosphate cements. Biomed Tech 2008; 53: 229-233.
3. Warnke P, Springer I, Wiltfang J et al. Growth and transplantation of a custom vascularised bone graft in a man. Lancet 2004; 364: 766-770.
4. Weingartner J, Proff P, Fanghanel J et al. Different bone sensitivity to malformations induced by procarbazine in fetal rats. J Physiol Pharmacol 2008; 59 (Suppl. 5): 17-25.
5. Wilson EM, Hsieh MM, Rotwein P.. Autocrine growth factor signaling by insulin-like growth factor-II mediates MyoD-stimulated myocyte maturation. J Biol Chem 2003; 278: 41109-41113.
6. Kjaer M. Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading. Physiol Rev 2004; 84: 649-698.
7. Ji JW, Mac Gabhann F, Popel AS. Skeletal muscle VEGF gradients in peripheral arterial disease: simulations of rest and exercise. Am J Physiol Heart Circ Physiol 2007; 293(6): H3740-H3749.
8. Ehrbar M, Zeisberger SM, Raeber GP, Hubbell JA, Schnell C, Zisch AH. The role of actively released fibrin-conjugated VEGF for VEGF receptor 2 gene activation and the enhancement of angiogenesis. Biomaterials 2008; 29: 1720-1729.
9. Gedrange T, Walter B, Tetzlaff I et al. Regional alterations in fiber type distribution, capillary density, and blood flow after lower jaw sagittal advancement in pig masticatory muscles. J Dent Res 2003; 82: 570-574.
10. Gedrange T, Lupp A, Kirsch C, Harze W, Klinger R. Influence of the sagittal advancement of mandibulae on myofibrillar ATPase activity and myosin heavy chain content in the masticatory muscles of pigs. Folia Histochem Cytobiol 2002; 40: 277-284
11. McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997; 387: 83-90.
12. DeChiara TM, Efstratiadis A, Robertson EJ. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 1990; 345: 78-80.
13. MacGregor J, Parkhouse WS. The potential role of insulinlike growth factors in skeletal muscle regeneration. Can J Appl Physiol 1996; 21: 236-250.
14. Marsh DR, Criswell DS, Hamilton MT, Booth FW. Association of insulin-like growth factor mRNA expressions with muscle regeneration in young, adult, and old rats. Am J Physiol 1997; 273: 353-358.
15. Vogel R, Tandler B, Haussler L, Jehnichen D, Brunig H. Melt spinning of poly(3-hydroxybutyrate) fibers for tissue engineering using α- cyclodextrin/polymer inclusion complexes as the nucleation agent. Macromol Biosci 2006: 6; 730-736.
16. Shishatskaya E, Voinova O, Goreva A, Mogilnaya O, Volova T. Biocompatibily of polyhydroxybutyrate microspheres: in vitro and in vivo evaluation. J Mater Sci Mater Med 2008; 19: 2493-2502.
17. Mack HB, Mai R, Lauer G et al. Adaptation of myosin heavy chain mRNA expression after implantation of poly(3)hydroxybutyrate scaffolds in rat m. latissimus dorsi. J Physiol Pharmacol 2008; 59(Suppl. 5): 95-103.
18. Talmadge RJ. Myosin heavy chain isoform expression following reduced neuromuscular activity: potential regulatory mechanisms. Muscle Nerv 2000; 23: 661-679.
19. Gedrange T, Mai R, Mack F et al. Evaluation of shape and size changes of bone and remodelled bone substitute after different fixation methods. J Physiol Pharmacol 2008; 59(Suppl. 5): 87-94.
20. Zietek M, Gedrange T, Mikulewicz M. Long term evaluation of biomaterial application in surgical treatment of periodontitis. J Physiol Pharmacol 2008; 59(Suppl. 5): 81-86.
21. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402-408.
22. Lee LY, Patel SR, Hackett NR, Mack CA, Polce DR, El-Sawy T. Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121, Ann Thorac Surg 2000; 69: 14-23.
23. Rutanen J, Rissanen TT, Kivela A, Vajanto I, Yla-Herttuala S. Clinical applications of vascular gene therapy. Curr Cardiol Rep 2001; 3: 29-36.
24. Peirce SM, Price RJ, Skalak TC. Spatial and temporal control of angiogenesis and arterialization using focal applications of VEGF164 and Ang-1. Am J Physiol Heart Circ Physiol 2004; 286: H918-H925.
25. Lassar A, Munsterberg A. Wiring diagrams: regulatory circuits and the control of skeletal myogenesis. Curr Opin Cell Biol 1994; 6: 432-442.
26. Naya FS, Olson E. MEF2: a transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation. Curr Opin Cell Biol 1999; 11: 683-688.
27. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. Mice carrying null mutations of the genes encoding insulinlike growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 1993; 75: 59-72.
28. Bauer R, Gedrange T, Bauer K, Walter B. Intrauterine growth restriction induces increased capillary density and accelerated type I fiber maturation in newborn pig skeletal muscles. J Perinat Med 2006; 34: 235-242.
29. Caroni P, Schneider C, Kiefer MC, Zapf J. Role of muscle insulin-like growth factors in nerve sprouting: suppression of terminal sprouting in paralyzed muscle by IGF-binding protein 4. J Cell Biol 1994; 124: 893-902.
30. Beck F, Samani NJ, Peuscow JD, Thorly B, Tregear GW, Coshlan JP. Histochemical localization of IGF-I and -II mRNA in the developing rat embryo. Development 1987; 101: 175-184.
31. Montarras D, Aurade F, Johnson T, Ilan J, Gros F, Pinset C. Autonomous differentiation in the mouse myogenic cell line, C2, involves a mutual positive control between insulin like growth factor II and MyoD, operating as early as the myoblast stage. J Cell Sci 1996; 109: 551-560.
32. Ji S, Losinski RL, Cornelius SG et al. Myostatin expression in porcine tissues: tissue specificity and developmental and postnatal regulation. Am J Physiol 1998; 275(4): H1265-H1273.
33. McCroskery S, Thomas M, Platt L et al. Improved muscle healing through enhanced regeneration and reduced fibrosis in myostatin-null mice. J Cell Sci 2005; 1: 3531-3541.
34. McCroskery S, Thomas M, Maxwell L, Sharma M, Kambadur R. Myostatin negatively regulates satellite cell activation and self-renewal. J Cell Biol 2003; 162: 1135-1147.
35. Wehling M, Cai B, Tidball JG. Modulation of myostatin expression during modified muscle use. FASEB J 2000; 14: 103-110.
36. Cieslak D, Blicharski T, Kapelanski W, Pierzchala M. Investigation of polymorphisms in the porcine myostatin (GDF8; MSTN) gene. Czech J Anim Sci 2003; 48: 69-75.